Healthcare provider profile · identity verified

Caryn Jackson, MD

Internal Medicine · YAKIMA, WA · NPI 1952495285

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	401	114
Lisinopril	Lisinopril	393	115
Albuterol Sulfate Hfa	Albuterol Sulfate	331	88
Omeprazole	Omeprazole	273	90
Oxycodone Hcl	Oxycodone Hcl	231	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	219	28
Losartan Potassium	Losartan Potassium	209	60
Levothyroxine Sodium	Levothyroxine Sodium	204	60
Jardiance	Empagliflozin	203	63
Amlodipine Besylate	Amlodipine Besylate	195	63
Rosuvastatin Calcium	Rosuvastatin Calcium	180	50
Diclofenac Sodium	Diclofenac Sodium	174	68
Montelukast Sodium	Montelukast Sodium	166	55
Gabapentin	Gabapentin	162	49
Metformin Hcl	Metformin Hcl	159	54
Metoprolol Succinate	Metoprolol Succinate	159	47
Ibuprofen	Ibuprofen	150	51
Famotidine	Famotidine	141	43
Ozempic	Semaglutide	132	22
Fluticasone Propionate	Fluticasone Propionate	127	48
Glipizide Er	Glipizide	109	28
Trulicity	Dulaglutide	106	17
Hydrochlorothiazide	Hydrochlorothiazide	98	33
Tramadol Hcl	Tramadol Hcl	95	18
Potassium Chloride	Potassium Chloride	94	35
Trazodone Hcl	Trazodone Hcl	92	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	16
Furosemide	Furosemide	89	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	36
Meloxicam	Meloxicam	83	28
Citalopram Hbr	Citalopram Hydrobromide	81	21
Metoprolol Tartrate	Metoprolol Tartrate	81	20
Hydralazine Hcl	Hydralazine Hcl	80	19
Chlorthalidone	Chlorthalidone	78	26
Carvedilol	Carvedilol	73	22
Tamsulosin Hcl	Tamsulosin Hcl	72	27
Lorazepam	Lorazepam	70	11
Pregabalin	Pregabalin	70	17
Escitalopram Oxalate	Escitalopram Oxalate	67	19
Baclofen	Baclofen	65	30
Duloxetine Hcl	Duloxetine Hcl	59	13
Metformin Hcl Er	Metformin Hcl	59	22
Spiriva Respimat	Tiotropium Bromide	59	suppressed
Eliquis	Apixaban	58	14
Sertraline Hcl	Sertraline Hcl	57	17
Simvastatin	Simvastatin	57	20
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	56	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	56	23
Tizanidine Hcl	Tizanidine Hcl	55	20
Ondansetron Odt	Ondansetron	51	18
Pravastatin Sodium	Pravastatin Sodium	49	13
Humalog Kwikpen U-100	Insulin Lispro	47	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	47	40
Clopidogrel	Clopidogrel Bisulfate	46	11
Bupropion Xl	Bupropion Hcl	45	16
Hydroxyzine Hcl	Hydroxyzine Hcl	45	16
Farxiga	Dapagliflozin Propanediol	44	13
Mirtazapine	Mirtazapine	44	14
Nifedipine Er	Nifedipine	43	14
Spironolactone	Spironolactone	43	12
Fluoxetine Hcl	Fluoxetine Hcl	42	15
Quetiapine Fumarate	Quetiapine Fumarate	41	13
Amitriptyline Hcl	Amitriptyline Hcl	38	12
Allopurinol	Allopurinol	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	14
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Clonazepam	Clonazepam	36	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	35	suppressed
Fluconazole	Fluconazole	35	17
Glipizide	Glipizide	35	11
Nystatin	Nystatin	35	13
Buspirone Hcl	Buspirone Hcl	34	suppressed
Januvia	Sitagliptin Phosphate	34	16
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	22
Pantoprazole Sodium	Pantoprazole Sodium	33	12
Ventolin Hfa	Albuterol Sulfate	33	11
Naproxen	Naproxen	32	14
Prazosin Hcl	Prazosin Hcl	32	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	17
Bydureon Bcise	Exenatide Microspheres	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	28	28
Azithromycin	Azithromycin	28	23
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Levemir Flexpen	Insulin Detemir	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Estradiol	Estradiol	25	suppressed
Morphine Sulfate	Morphine Sulfate	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	23
Ezetimibe	Ezetimibe	23	suppressed
Icosapent Ethyl	Icosapent Ethyl	23	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	22	17
Prednisone	Prednisone	22	14
Risperidone	Risperidone	22	suppressed
Lidocaine	Lidocaine	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	14
Alprazolam	Alprazolam	20	suppressed
Cephalexin	Cephalexin	20	13
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Olanzapine	Olanzapine	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Humalog	Insulin Lispro	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	12
Promethazine Hcl	Promethazine Hcl	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Atenolol	Atenolol	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Serevent Diskus	Salmeterol Xinafoate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Viberzi	Eluxadoline	12	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error